Cargando…
Differential LRRK2 signalling and gene expression in WT-LRRK2 and G2019S-LRRK2 mouse microglia treated with zymosan and MLi2
INTRODUCTION: Mutations in the Leucine Rich Repeat Kinase 2 (LRRK2) gene cause autosomal dominant Parkinson’s disease (PD) with the most common causative mutation being the LRRK2 p.G2019S within the kinase domain. LRRK2 protein is highly expressed in the human brain and also in the periphery, and hi...
Autores principales: | Nazish, Iqra, Mamais, Adamantios, Mallach, Anna, Bettencourt, Conceicao, Kaganovich, Alice, Warner, Tom, Hardy, John, Lewis, Patrick A., Pocock, Jennifer, Cookson, Mark R, Bandopadhyay, Rina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10515904/ https://www.ncbi.nlm.nih.gov/pubmed/37745519 http://dx.doi.org/10.1101/2023.09.14.557532 |
Ejemplares similares
-
Analysis of macroautophagy related proteins in G2019S LRRK2 Parkinson’s disease brains with Lewy body pathology
por: Mamais, Adamantios, et al.
Publicado: (2018) -
Inhibition of LRRK2 kinase activity stimulates macroautophagy()
por: Manzoni, Claudia, et al.
Publicado: (2013) -
Perspective on the current state of the LRRK2 field
por: Taymans, Jean-Marc, et al.
Publicado: (2023) -
Detection of endogenous S1292 LRRK2 autophosphorylation in mouse tissue as a readout for kinase activity
por: Kluss, Jillian H., et al.
Publicado: (2018) -
Abrogation of LRRK2 dependent Rab10 phosphorylation with TLR4 activation and alterations in evoked cytokine release in immune cells
por: Nazish, Iqra, et al.
Publicado: (2021)